Drug · DIN 02501848
XENLETA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 27, 2024.
- Drug Identification Number (DIN)
- 02501848
- Company (DIN owner)
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lefamulin J01XX12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEFAMULIN (LEFAMULIN ACETATE) | 600 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 10, 2020: NOC 23888New Drug Submission (NDS)
Other DINs named XENLETA
- DIN 02501821 · Cancelled Pre Market